Advanced search
Publication Cover
Scandinavian Journal of Urology and Nephrology Volume 16, 1982 - Issue 1
Submit an article Journal homepage
4
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Renal Function as an Indicator of Prognosis in Malignant Essential Hypertension

Hans HerlitzFrom the Section of Nephrology, Department of Medicine I, Sahlgren's Hospital and Hypertension Section, Department of Medicine, östra Hospital, University of Göteborg, Göteborg, Sweden
,
Thorkell GudbrandssonFrom the Section of Nephrology, Department of Medicine I, Sahlgren's Hospital and Hypertension Section, Department of Medicine, östra Hospital, University of Göteborg, Göteborg, Sweden
&
Lennart HanssonFrom the Section of Nephrology, Department of Medicine I, Sahlgren's Hospital and Hypertension Section, Department of Medicine, östra Hospital, University of Göteborg, Göteborg, Sweden
Pages 51-55 | Received 21 Mar 1981, Published online: 15 Feb 2010

REFERENCES

  • Breckenridge, A., Dollery, C. T. & Parry, E. H. O. 1970. Prognosis of treated hypertension. Changes in life expectancy and causes of death between 1952 and 1961. Q J Med 39, 411.
  • Bröchner-Mortensen, J. 1972. A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest 30, 271.
  • Davidov, M., Mroczek, W., Gavrilovich, L. & Finnerty, F., Jr. 1975. Long-term follow-up of aggressive medical therapy of accelerated hypertension with azotemia. Angiology 26, 396.
  • Granérus, G. & Aurell, M. 1981. Reference values for 51Cr-EDTA clearance as a measure of glomerular filtration rate. J Clin Lab Invest, in press.
  • Gudbrandsson, T., Hansson, L., Herlitz, H. & Andrén, L. 1979. Malignant hypertension improving prognosis in a rare disease. Acta Med Scand, 206, 495.
  • Gudbrandsson, T., Hansson, L., Herlitz, H., Lindholm, L. & Nilsson, L. Å. 1981. Immunological changes in patients with previous malignant essential hypertension. Lancet 1, 406.
  • Harington, M., Kincaid-Smith, P. & McMichael, J. 1959. Results of treatment in malignant hypertension. A seven year experience in 94 cases. Br Med J 2, 969.
  • Hood, B., Örndahl, G. & Björk, S. 1970. Survival and mortality in malignant (grade IV) and grade III hypertension. Trends in consecutive, actively treated groups. Acta Med Scand 187, 291.
  • Keith, N. M., Wagener, H. P. & Barker, N. W. 1939. Some different types of essential hypertension: Their course and prognosis. Am J Med Sci 196, 332.
  • Kincaid-Smith, P. 1976. The effects of antihypertensive treatment on the kidney. In Systemic effects of antihypertensive agents (ed. M. P.Sambhi), pp. 21–33. Stratton Intercontinental Medical Book Corp., New York.
  • Kincaid-Smith, P. 1980. Malignant hypertension: mechanisms and management. Pharmac Ther 9, 245.
  • Merrill, J. P. 1962. Hypertensive vascular disease. In Principles of internal medicine (ed. T. R.Harrison, W. R.Resnik, M. M.Wintroke, G. W.Thorn, R. D.Adams and I. L.Bennett Jr), pp. 1359. McGraw-Hill, New York.
  • Mitchell, H. C., Graham, R. M. & Pettinger, W. A. 1980. Renal function during long-term treatment of hypertension with minoxidil. Comparison of benign and malignant hypertension. Ann Int Med 93, 676.
  • Mroczek, W. J., Davidov, M. E., Gavrilovich, L. & Finnerty, F. A. 1969. The value of aggressive therapy in the hypertensive patient with azotemia. Circulation 40, 893.
  • World Health Organisation 1978. Arterial hypertension. Report of a WHO Expert Committee. WHO Technical Report Series 628, Geneva.
  • Woods, J. W. & Blythe, W. B. 1967. Management of malignant hypertension complicated by renal insufficiency. New Engl J Med 277, 57.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.